Paper17637
Interactions of C-reactive protein with the first component of human complement.
Claus DR and 4 others. J Immunol, 1977. Cited by 122 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Interactions of C-reactive protein with the first component of human complement. Papers, record 17637. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17637
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| C-Reactive Protein | Major topic |
| Complement C1 | Major topic |
| Complement System Proteins | Major topic |
| Binding Sites | |
| Erythrocytes | |
| Humans | |
| Polysaccharides, Bacterial | |
| Streptococcus pneumoniae |
Source PubMed
Cited by38
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 122 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41,214,213 | C-reactive protein is a broad-spectrum capsule-binding receptor for hepatic capture of blood-borne bacteria. | EMBO J | 2025 | https://conductscience.org/library/papers/41214213 | PubMed |
| 32,923,708 | An overview on human serum lectins. | Heliyon | 2020 | https://conductscience.org/library/papers/32923708 | PubMed |
| 32,765,664 | C-reactive protein and cardiovascular disease: From animal studies to the clinic (Review). | Exp Ther Med | 2020 | https://conductscience.org/library/papers/32765664 | PubMed |
| 24,167,754 | Pentraxins: structure, function, and role in inflammation. | ISRN Inflamm | 2013 | https://conductscience.org/library/papers/24167754 | PubMed |
| 24,084,772 | Validation of the prognostic relevance of plasma C-reactive protein levels in soft-tissue sarcoma patients. | Br J Cancer | 2013 | https://conductscience.org/library/papers/24084772 | PubMed |
| 21,734,248 | Pathogenesis and pathophysiology of pneumococcal meningitis. | Clin Microbiol Rev | 2011 | https://conductscience.org/library/papers/21734248 | PubMed |
| 20,605,879 | The complex nature of serum C3 and C4 as biomarkers of lupus renal flare. | Lupus | 2010 | https://conductscience.org/library/papers/20605879 | PubMed |
| 19,075,776 | The protective function of human C-reactive protein in mouse models of Streptococcus pneumoniae infection. | Endocr Metab Immune Disord Drug Targets | 2008 | https://conductscience.org/library/papers/19075776 | PubMed |
| 17,244,159 | Studies on the interactions between C-reactive protein and complement proteins. | Immunology | 2007 | https://conductscience.org/library/papers/17244159 | PubMed |
| 16,547,275 | Role of the property of C-reactive protein to activate the classical pathway of complement in protecting mice from pneumococcal infection. | J Immunol | 2006 | https://conductscience.org/library/papers/16547275 | PubMed |
| 16,179,087 | Complement activation capacity in plasma before and during high-dose prednisolone treatment and tapering in exacerbations of Crohn's disease and ulcerative colitis. | BMC Gastroenterol | 2005 | https://conductscience.org/library/papers/16179087 | PubMed |
| 12,102,655 | Binding of C-reactive protein to modified low-density-lipoprotein particles: identification of cholesterol as a novel ligand for C-reactive protein. | Biochem J | 2002 | https://conductscience.org/library/papers/12102655 | PubMed |
| 8,439,977 | Therapeutic effects of a synthetic peptide of C-reactive protein in pre-clinical tumor models. | Cancer Immunol Immunother | 1993 | https://conductscience.org/library/papers/8439977 | PubMed |
| 8,424,463 | Rabbits with elevated serum C-reactive protein exhibit diminished neutrophil infiltration and vascular permeability in C5a-induced alveolitis. | Am J Pathol | 1993 | https://conductscience.org/library/papers/8424463 | PubMed |
| 7,092,339 | Relationship between urinary sialylated saccharides, serum amyloid A protein, and C-reactive protein in rheumatoid arthritis and systemic lupus erythematosus. | Ann Rheum Dis | 1982 | https://conductscience.org/library/papers/7092339 | PubMed |
| 7,086,355 | Low density lipoprotein and very low density lipoprotein are selectively bound by aggregated C-reactive protein. | J Exp Med | 1982 | https://conductscience.org/library/papers/7086355 | PubMed |
| 7,061,105 | Activation of platelets by modified C-reactive protein. | Immunology | 1982 | https://conductscience.org/library/papers/7061105 | PubMed |
| 6,971,771 | Studies on circulating soluble immune complexes of the liver disease. 6. Comparative studies of 125I-pRF inhibition assay, 125I-Clq inhibition assay and 125I-Clq binding assay. | Gastroenterol Jpn | 1981 | https://conductscience.org/library/papers/6971771 | PubMed |
| 6,821,631 | Identification of PEG-precipitable serum factor associated with malignant lymphoma as C-reactive protein. | Br J Cancer | 1983 | https://conductscience.org/library/papers/6821631 | PubMed |
| 6,561,065 | Inhibition of liver metastases in murine colon adenocarcinoma by liposomes containing human C-reactive protein or crude lymphokine. | Cancer Immunol Immunother | 1984 | https://conductscience.org/library/papers/6561065 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| CRP | 1,401 | PubTator's text mining | https://conductscience.org/library/genes/1401 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/17637
GET https://conductscience.org/api/papers/v1/17637/cited_by?page=2